PRA

NEUTRALM&A

ProAssurance Corporation

2026-03-20

Price

$24.58

+0.45%

Score5.8Watchlist

Signals3/8 DNA3/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.7xvs 20d avg

Analysis

ProAssurance (PRA) is exhibiting classic merger arbitrage behavior, anchored by its pending $25.00 per share all-cash acquisition by The Doctors Company. Recent news of a massive Q4 earnings beat—$0.82 actual versus a $0.24 estimate—further de-risks the target's balance sheet, perfectly aligning with the QUIET_ACCUMULATION and PERFECT_STACK signals as institutional arbitrageurs steadily collect the remaining spread. In a CAUTION regime dominated by geopolitical fear, PRA acts as a synthetic bond; the fact that high yield credit spreads remain remarkably tight (0.90%) ensures that M&A financing remains secure, making this equity a high-conviction safe haven.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACKQUIET ACCUMULATIONSMA BOUNCESTOCHASTIC POPCHURNING

Key Takeaways

Actionable Thesis: PRA is a definitive merger arbitrage play, offering a highly insulated ~1.7% spread up to the $25.00 cash buyout price.
Key Risk: Regulatory delays in the remaining pending states (CA, PA, TX) could push the closing timeline past the expected Q2 2026 window, creating opportunity cost drag.
What to Watch: Final insurance regulatory approvals and the formal deal closing announcement expected in the first half of 2026.

← Back to 2026-03-20 View Full PRA History →Yahoo Finance &nearr;